| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.979 | 0.002 | 0.979 | Cyclooxygenase inhibitor | 0.954 0.002 DBMET00169 0.704 0.003 DBMET00170 0.82 0.003 DBMET00171 0.82 0.003 DBMET00172 0.954 0.002 DBMET01838 0.827 0.003 DBMET01294 0.782 0.003 DBMET01292 | ||
| 0.971 | 0.002 | 0.971 | Cyclooxygenase 2 inhibitor | 0.941 0.002 DBMET00169 0.656 0.003 DBMET00170 0.74 0.003 DBMET00171 0.74 0.003 DBMET00172 0.941 0.002 DBMET01838 0.77 0.003 DBMET01294 0.752 0.003 DBMET01292 | ||
| 0.957 | 0.002 | 0.957 | Cyclooxygenase 1 inhibitor | 0.8 0.003 DBMET00169 0.584 0.004 DBMET00170 0.78 0.003 DBMET00171 0.78 0.003 DBMET00172 0.8 0.003 DBMET01838 0.632 0.004 DBMET01294 0.691 0.004 DBMET01292 | ||
| 0.923 | 0.002 | 0.944 | Non-steroidal antiinflammatory agent | 0.831 0.003 DBMET00169 0.677 0.004 DBMET00170 0.745 0.003 DBMET00171 0.745 0.003 DBMET00172 0.831 0.003 DBMET01838 0.944 0.002 DBMET01294 0.572 0.005 DBMET01292 | DBMET01294 | |
| 0.739 | 0.024 | 0.899 | Antiinflammatory | 0.899 0.005 DBMET00169 0.742 0.024 DBMET00170 0.642 0.043 DBMET00171 0.642 0.043 DBMET00172 0.899 0.005 DBMET01838 0.899 0.005 DBMET01294 0.517 0.081 DBMET01292 | DBMET01294 | |
| 0.479 | 0.004 | 0.497 | Tyrosine 3 hydroxylase inhibitor | 0.426 0.006 DBMET00169 0.396 0.009 DBMET00170 0.497 0.004 DBMET00171 0.497 0.004 DBMET00172 0.426 0.006 DBMET01838 0.443 0.005 DBMET01292 | DBMET00172 | |
| 0.45 | 0.036 | 0.482 | 5 Hydroxytryptamine release stimulant | 0.424 0.041 DBMET00169 0.457 0.035 DBMET00170 0.335 0.06 DBMET00171 0.335 0.06 DBMET00172 0.424 0.041 DBMET01838 0.372 0.052 DBMET01294 0.482 0.03 DBMET01292 | DBMET01292 | |
| 0.439 | 0.028 | 0.439 | Lipoxygenase inhibitor | 0.264 0.091 DBMET00169 0.249 0.101 DBMET00171 0.249 0.101 DBMET00172 0.264 0.091 DBMET01838 0.254 0.098 DBMET01292 | ||
| 0.432 | 0.035 | 0.462 | Caspase 3 stimulant | 0.314 0.072 DBMET00169 0.295 0.081 DBMET00170 0.314 0.072 DBMET01838 0.318 0.071 DBMET01294 0.462 0.027 DBMET01292 | DBMET01292 | |
| 0.377 | 0.006 | 0.377 | 5-Lipoxygenase inhibitor | 0.105 0.06 DBMET00171 0.105 0.06 DBMET00172 | ||
| 0.347 | 0.016 | 0.347 | Protein kinase C nu inhibitor | 0.132 0.081 DBMET00169 0.132 0.081 DBMET01838 | ||
| 0.366 | 0.035 | 0.366 | Cardiotonic | |||
| 0.328 | 0.012 | 0.355 | Interleukin 6 antagonist | 0.355 0.01 DBMET00169 0.289 0.016 DBMET00170 0.327 0.012 DBMET00171 0.327 0.012 DBMET00172 0.355 0.01 DBMET01838 0.287 0.017 DBMET01294 0.226 0.029 DBMET01292 | DBMET01838 | |
| 0.401 | 0.09 | 0.74 | Cyclophilin D inhibitor | 0.399 0.091 DBMET00169 0.369 0.109 DBMET00170 0.547 0.038 DBMET00171 0.547 0.038 DBMET00172 0.399 0.091 DBMET01838 0.74 0.01 DBMET01294 | DBMET01294 | |
| 0.367 | 0.08 | 0.367 | MAP kinase kinase 6 inhibitor | 0.254 0.185 DBMET00169 0.254 0.185 DBMET01838 0.238 0.206 DBMET01292 | ||
| 0.34 | 0.057 | 0.34 | Calcium channel activator | 0.29 0.102 DBMET00171 0.29 0.102 DBMET00172 0.305 0.087 DBMET01292 | ||
| 0.301 | 0.022 | 0.301 | Diuretic | 0.171 0.06 DBMET00169 0.171 0.06 DBMET01838 0.235 0.033 DBMET01294 0.129 0.095 DBMET01292 | ||
| 0.266 | 0.014 | 0.266 | Topoisomerase I inhibitor | 0.183 0.031 DBMET01294 0.224 0.021 DBMET01292 | ||
| 0.275 | 0.036 | 0.435 | Peptidyltransferase inhibitor | 0.333 0.015 DBMET00169 0.325 0.017 DBMET00170 0.33 0.016 DBMET00171 0.33 0.016 DBMET00172 0.333 0.015 DBMET01838 0.435 0.005 DBMET01294 0.268 0.039 DBMET01292 | DBMET01294 | |
| 0.239 | 0.008 | 0.239 | Protein kinase C mu inhibitor | 0.117 0.043 DBMET00169 0.117 0.043 DBMET01838 | ||
| 0.335 | 0.108 | 0.414 | 15-Lipoxygenase inhibitor | 0.223 0.189 DBMET00169 0.223 0.189 DBMET01838 0.414 0.069 DBMET01292 | DBMET01292 | |
| 0.337 | 0.116 | 0.469 | Analgesic | 0.398 0.085 DBMET00169 0.469 0.059 DBMET00170 0.227 0.206 DBMET00171 0.227 0.206 DBMET00172 0.398 0.085 DBMET01838 0.33 0.12 DBMET01294 0.237 0.195 DBMET01292 | DBMET00170 | |
| 0.314 | 0.107 | 0.314 | Antiobesity | 0.223 0.183 DBMET00171 0.223 0.183 DBMET00172 0.247 0.159 DBMET01294 | ||
| 0.213 | 0.01 | 0.213 | Antineoplastic alkaloid | 0.153 0.027 DBMET00169 0.153 0.027 DBMET01838 | ||
| 0.206 | 0.004 | 0.232 | Liver X receptor agonist | 0.138 0.005 DBMET00169 0.12 0.006 DBMET00170 0.232 0.004 DBMET00171 0.232 0.004 DBMET00172 0.138 0.005 DBMET01838 0.052 0.021 DBMET01294 0.184 0.004 DBMET01292 | DBMET00172 | |
| 0.296 | 0.096 | 0.597 | Transcription factor NF kappa B inhibitor | 0.37 0.071 DBMET00169 0.31 0.089 DBMET00170 0.274 0.111 DBMET00171 0.274 0.111 DBMET00172 0.37 0.071 DBMET01838 0.597 0.031 DBMET01294 0.27 0.113 DBMET01292 | DBMET01294 | |
| 0.204 | 0.006 | 0.261 | CDC25A inhibitor | 0.261 0.004 DBMET00169 0.081 0.042 DBMET00170 0.261 0.004 DBMET01838 0.143 0.014 DBMET01294 | DBMET01838 | |
| 0.263 | 0.069 | 0.276 | 5 Hydroxytryptamine uptake stimulant | 0.234 0.098 DBMET00169 0.245 0.086 DBMET00170 0.229 0.105 DBMET00171 0.229 0.105 DBMET00172 0.234 0.098 DBMET01838 0.276 0.059 DBMET01292 | DBMET01292 | |
| 0.255 | 0.064 | 0.255 | Potassium channel blocker | |||
| 0.339 | 0.155 | 0.45 | Caspase 9 stimulant | 0.45 0.083 DBMET00169 0.42 0.099 DBMET00170 0.344 0.15 DBMET00171 0.344 0.15 DBMET00172 0.45 0.083 DBMET01838 0.383 0.122 DBMET01294 0.313 0.18 DBMET01292 | DBMET01838 | |
| 0.261 | 0.078 | 0.365 | Aldehyde oxidase inhibitor | 0.227 0.092 DBMET00169 0.365 0.052 DBMET00171 0.365 0.052 DBMET00172 0.227 0.092 DBMET01838 | DBMET00172 | |
| 0.216 | 0.041 | 0.216 | 5 Hydroxytryptamine 3E antagonist | 0.197 0.067 DBMET01292 | ||
| 0.174 | 0.004 | 0.231 | Liver X receptor antagonist | 0.127 0.004 DBMET00169 0.093 0.005 DBMET00170 0.231 0.003 DBMET00171 0.231 0.003 DBMET00172 0.127 0.004 DBMET01838 0.034 0.019 DBMET01294 0.166 0.004 DBMET01292 | DBMET00172 | |
| 0.201 | 0.035 | 0.478 | Insulin secretagoues | 0.221 0.027 DBMET00169 0.191 0.04 DBMET00170 0.478 0.005 DBMET00171 0.478 0.005 DBMET00172 0.221 0.027 DBMET01838 0.327 0.01 DBMET01294 0.169 0.056 DBMET01292 | DBMET00172 | |
| 0.162 | 0.005 | 0.162 | ATPase (Vacuolar H+) inhibitor | 0.142 0.01 DBMET00169 0.142 0.01 DBMET01838 0.142 0.009 DBMET01294 | ||
| 0.157 | 0.005 | 0.172 | Aldosterone antagonist | 0.05 0.029 DBMET00169 0.071 0.014 DBMET00170 0.067 0.016 DBMET00171 0.067 0.016 DBMET00172 0.05 0.029 DBMET01838 0.172 0.004 DBMET01292 | DBMET01292 | |
| 0.246 | 0.1 | 0.274 | Insulysin inhibitor | 0.201 0.155 DBMET00169 0.274 0.076 DBMET00171 0.274 0.076 DBMET00172 0.201 0.155 DBMET01838 0.196 0.163 DBMET01292 | DBMET00172 | |
| 0.261 | 0.116 | 0.369 | Sodium/bile acid cotransporter inhibitor | 0.264 0.113 DBMET00169 0.248 0.13 DBMET00170 0.369 0.029 DBMET00171 0.369 0.029 DBMET00172 0.264 0.113 DBMET01838 0.23 0.15 DBMET01294 0.241 0.138 DBMET01292 | DBMET00172 | |
| 0.309 | 0.166 | 0.482 | Apoptosis agonist | 0.403 0.112 DBMET00169 0.369 0.129 DBMET00170 0.403 0.112 DBMET01838 0.482 0.08 DBMET01294 0.472 0.083 DBMET01292 | DBMET01294 | |
| 0.169 | 0.027 | 0.181 | Pregnane X receptor agonist | 0.143 0.067 DBMET00169 0.145 0.062 DBMET00170 0.181 0.018 DBMET00171 0.181 0.018 DBMET00172 0.143 0.067 DBMET01838 0.171 0.025 DBMET01292 | DBMET00172 | |
| 0.224 | 0.086 | 0.347 | Vasodilator | 0.16 0.143 DBMET00169 0.16 0.143 DBMET01838 0.347 0.034 DBMET01294 | DBMET01294 | |
| 0.171 | 0.035 | 0.171 | DNA intercalator | 0.139 0.048 DBMET01292 | ||
| 0.143 | 0.019 | 0.256 | ABCA1 expression enhancer | 0.143 0.019 DBMET00169 0.132 0.024 DBMET00170 0.256 0.006 DBMET00171 0.256 0.006 DBMET00172 0.143 0.019 DBMET01838 0.163 0.014 DBMET01292 | DBMET00172 | |
| 0.127 | 0.004 | 0.151 | DNA helicase inhibitor | 0.128 0.004 DBMET00169 0.106 0.005 DBMET00170 0.151 0.003 DBMET00171 0.151 0.003 DBMET00172 0.128 0.004 DBMET01838 0.096 0.006 DBMET01294 0.102 0.005 DBMET01292 | DBMET00172 | |
| 0.139 | 0.016 | 0.278 | Keratolytic | 0.087 0.04 DBMET00169 0.133 0.018 DBMET00170 0.218 0.007 DBMET00171 0.218 0.007 DBMET00172 0.087 0.04 DBMET01838 0.278 0.004 DBMET01292 | DBMET01292 | |
| 0.127 | 0.005 | 0.127 | Potassium channel (Inward rectifier) blocker | |||
| 0.263 | 0.146 | 0.43 | Histamine release inhibitor | 0.22 0.18 DBMET00171 0.22 0.18 DBMET00172 0.43 0.06 DBMET01294 | DBMET01294 | |
| 0.115 | 0.006 | 0.115 | Mineralocorticoid receptor antagonist | |||
| 0.152 | 0.044 | 0.152 | Cathepsin H inhibitor | 0.116 0.081 DBMET00171 0.116 0.081 DBMET00172 0.136 0.058 DBMET01292 | ||
| 0.11 | 0.005 | 0.2 | Liver X receptor beta agonist | 0.043 0.013 DBMET00169 0.035 0.021 DBMET00170 0.2 0.003 DBMET00171 0.2 0.003 DBMET00172 0.043 0.013 DBMET01838 0.055 0.009 DBMET01292 | DBMET00172 | |
| 0.125 | 0.024 | 0.125 | Macrophage migration inhibitory factor inhibitor | 0.089 0.042 DBMET00169 0.076 0.056 DBMET00171 0.076 0.056 DBMET00172 0.089 0.042 DBMET01838 | ||
| 0.117 | 0.019 | 0.117 | Focal adhesion kinase 1 inhibitor | 0.071 0.061 DBMET00169 0.071 0.061 DBMET01838 0.102 0.029 DBMET01292 | ||
| 0.133 | 0.035 | 0.189 | Estrogen antagonist | 0.189 0.014 DBMET01292 | DBMET01292 | |
| 0.103 | 0.007 | 0.125 | Nitric oxide donor | 0.12 0.004 DBMET00169 0.08 0.022 DBMET00170 0.082 0.021 DBMET00171 0.082 0.021 DBMET00172 0.12 0.004 DBMET01838 0.125 0.004 DBMET01294 0.077 0.025 DBMET01292 | DBMET01294 | |
| 0.103 | 0.008 | 0.103 | Potassium channel intermediate-conductance Ca-activated blocker | 0.08 0.018 DBMET01292 | ||
| 0.122 | 0.029 | 0.122 | Estrogen receptor beta antagonist | 0.111 0.044 DBMET01292 | ||
| 0.093 | 0.004 | 0.181 | Liver X receptor alpha antagonist | 0.062 0.005 DBMET00169 0.054 0.005 DBMET00170 0.181 0.003 DBMET00171 0.181 0.003 DBMET00172 0.062 0.005 DBMET01838 0.027 0.025 DBMET01294 0.071 0.004 DBMET01292 | DBMET00172 | |
| 0.205 | 0.117 | 0.454 | Immunostimulant | 0.207 0.116 DBMET00169 0.207 0.116 DBMET01838 0.454 0.036 DBMET01294 | DBMET01294 | |
| 0.139 | 0.055 | 0.324 | Topoisomerase II inhibitor | 0.12 0.067 DBMET00169 0.129 0.06 DBMET00170 0.12 0.067 DBMET01838 0.148 0.05 DBMET01294 0.324 0.015 DBMET01292 | DBMET01292 | |
| 0.212 | 0.13 | 0.314 | Gastrin inhibitor | 0.18 0.179 DBMET00169 0.181 0.178 DBMET00170 0.314 0.024 DBMET00171 0.314 0.024 DBMET00172 0.18 0.179 DBMET01838 0.213 0.129 DBMET01292 | DBMET00172 | |
| 0.175 | 0.094 | 0.175 | Focal adhesion kinase 2 inhibitor | |||
| 0.093 | 0.012 | 0.093 | Elastase inhibitor | 0.058 0.032 DBMET00169 0.048 0.046 DBMET00171 0.048 0.046 DBMET00172 0.058 0.032 DBMET01838 0.048 0.046 DBMET01292 | ||
| 0.089 | 0.011 | 0.089 | Transcription factor RelA inhibitor | 0.079 0.018 DBMET00169 0.066 0.038 DBMET00170 0.079 0.018 DBMET01838 0.074 0.024 DBMET01292 | ||
| 0.079 | 0.007 | 0.262 | Liver X receptor alpha agonist | 0.055 0.015 DBMET00169 0.047 0.022 DBMET00170 0.262 0.003 DBMET00171 0.262 0.003 DBMET00172 0.055 0.015 DBMET01838 0.059 0.013 DBMET01292 | DBMET00172 | |
| 0.088 | 0.018 | 0.088 | Phosphodiesterase 4C inhibitor | |||
| 0.121 | 0.053 | 0.194 | Mucolytic | 0.194 0.015 DBMET00169 0.156 0.029 DBMET00170 0.178 0.019 DBMET00171 0.178 0.019 DBMET00172 0.194 0.015 DBMET01838 0.176 0.02 DBMET01294 | DBMET01838 | |
| 0.141 | 0.073 | 0.141 | Heat shock protein 70 antagonist | 0.129 0.126 DBMET01294 | ||
| 0.22 | 0.155 | 0.22 | Thioredoxin glutathione reductase inhibitor | |||
| 0.068 | 0.004 | 0.068 | Cathepsin F inhibitor | 0.057 0.007 DBMET00169 0.052 0.01 DBMET00170 0.061 0.005 DBMET00171 0.061 0.005 DBMET00172 0.057 0.007 DBMET01838 0.047 0.017 DBMET01294 0.062 0.005 DBMET01292 | ||
| 0.117 | 0.053 | 0.351 | Expectorant | 0.179 0.025 DBMET00169 0.135 0.042 DBMET00170 0.154 0.034 DBMET00171 0.154 0.034 DBMET00172 0.179 0.025 DBMET01838 0.351 0.006 DBMET01294 | DBMET01294 | |
| 0.156 | 0.092 | 0.187 | ATPase inhibitor | 0.187 0.05 DBMET01294 | DBMET01294 | |
| 0.105 | 0.043 | 0.105 | Androgen antagonist | 0.081 0.064 DBMET00169 0.081 0.064 DBMET01838 | ||
| 0.104 | 0.043 | 0.279 | Triose-phosphate isomerase inhibitor | 0.131 0.027 DBMET00169 0.108 0.04 DBMET00170 0.279 0.005 DBMET00171 0.279 0.005 DBMET00172 0.131 0.027 DBMET01838 0.219 0.009 DBMET01294 0.087 0.064 DBMET01292 | DBMET00172 | |
| 0.08 | 0.019 | 0.08 | Bromodomain-containing protein 4 inhibitor | 0.058 0.035 DBMET01292 | ||
| 0.063 | 0.003 | 0.063 | Potassium channel (Inward rectifier) 1 blocker | 0.03 0.023 DBMET01292 | ||
| 0.227 | 0.169 | 0.524 | Immunosuppressant | 0.518 0.028 DBMET00169 0.52 0.028 DBMET00170 0.518 0.028 DBMET01838 0.524 0.027 DBMET01294 | DBMET01294 | |
| 0.063 | 0.005 | 0.188 | Liver X receptor beta antagonist | 0.049 0.009 DBMET00169 0.037 0.014 DBMET00170 0.188 0.002 DBMET00171 0.188 0.002 DBMET00172 0.049 0.009 DBMET01838 0.051 0.008 DBMET01292 | DBMET00172 | |
| 0.081 | 0.023 | 0.081 | Protein kinase C eta inhibitor | |||
| 0.112 | 0.057 | 0.22 | AMP-activated protein kinase stimulant | 0.093 0.081 DBMET00169 0.093 0.081 DBMET01838 0.22 0.009 DBMET01294 | DBMET01294 | |
| 0.168 | 0.113 | 0.168 | Neurotrophic factor enhancer | 0.158 0.127 DBMET00169 0.158 0.127 DBMET01838 | ||
| 0.065 | 0.011 | 0.065 | Glycine transporter 1 inhibitor | 0.051 0.015 DBMET00171 0.051 0.015 DBMET00172 0.063 0.012 DBMET01292 | ||
| 0.093 | 0.04 | 0.093 | Phosphodiesterase 4D inhibitor | |||
| 0.084 | 0.031 | 0.084 | Elastase 1 inhibitor | 0.065 0.053 DBMET00171 0.065 0.053 DBMET00172 | ||
| 0.064 | 0.011 | 0.098 | G protein-coupled receptor agonist | 0.098 0.005 DBMET00171 0.098 0.005 DBMET00172 0.085 0.007 DBMET01292 | DBMET00172 | |
| 0.072 | 0.02 | 0.072 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.063 0.027 DBMET00169 0.058 0.032 DBMET00170 0.062 0.027 DBMET00171 0.062 0.027 DBMET00172 0.063 0.027 DBMET01838 0.066 0.024 DBMET01292 | ||
| 0.072 | 0.02 | 0.128 | Thromboxane A2 antagonist | 0.06 0.028 DBMET00169 0.056 0.032 DBMET00170 0.128 0.005 DBMET00171 0.128 0.005 DBMET00172 0.06 0.028 DBMET01838 0.057 0.03 DBMET01292 | DBMET00172 | |
| 0.142 | 0.09 | 0.226 | Interferon gamma antagonist | 0.146 0.083 DBMET00169 0.137 0.098 DBMET00170 0.138 0.096 DBMET00171 0.138 0.096 DBMET00172 0.146 0.083 DBMET01838 0.226 0.033 DBMET01294 | DBMET01294 | |
| 0.194 | 0.142 | 0.195 | Transcription factor STAT3 inhibitor | 0.195 0.14 DBMET01292 | DBMET01292 | |
| 0.085 | 0.035 | 0.085 | Leukotriene synthesis inhibitor | |||
| 0.074 | 0.024 | 0.14 | Thromboxane antagonist | 0.056 0.035 DBMET00169 0.053 0.038 DBMET00170 0.14 0.005 DBMET00171 0.14 0.005 DBMET00172 0.056 0.035 DBMET01838 0.058 0.034 DBMET01292 | DBMET00172 | |
| 0.102 | 0.053 | 0.114 | Lanosterol 14 alpha demethylase inhibitor | 0.114 0.037 DBMET00171 0.114 0.037 DBMET00172 0.088 0.075 DBMET01292 | DBMET00172 | |
| 0.064 | 0.016 | 0.064 | Potassium channel (Inward rectifier) activator | 0.06 0.02 DBMET01292 | ||
| 0.125 | 0.078 | 0.336 | Amylase inhibitor | 0.167 0.057 DBMET00169 0.167 0.057 DBMET01838 0.336 0.014 DBMET01294 | DBMET01294 | |
| 0.058 | 0.011 | 0.058 | DNA gyrase subunit A inhibitor | |||
| 0.18 | 0.134 | 0.602 | Hypoglycemic | 0.182 0.132 DBMET00169 0.394 0.029 DBMET00171 0.394 0.029 DBMET00172 0.182 0.132 DBMET01838 0.602 0.008 DBMET01294 0.164 0.156 DBMET01292 | DBMET01294 | |
| 0.193 | 0.148 | 0.193 | Transcription factor STAT inhibitor | 0.183 0.163 DBMET01292 | ||
| 0.06 | 0.016 | 0.06 | Potassium channel (ATP-sensitive) activator | 0.056 0.02 DBMET01292 | ||
| 0.078 | 0.038 | 0.078 | Phosphodiesterase 4B inhibitor | |||
| 0.15 | 0.112 | 0.222 | Succinate dehydrogenase inhibitor | 0.222 0.034 DBMET00171 0.222 0.034 DBMET00172 | DBMET00172 | |
| 0.061 | 0.024 | 0.074 | Glycine transporter inhibitor | 0.074 0.019 DBMET00171 0.074 0.019 DBMET00172 0.062 0.024 DBMET01292 | DBMET00172 | |
| 0.048 | 0.012 | 0.06 | Glucose-dependent insulinotropic receptor agonist | 0.032 0.028 DBMET00171 0.032 0.028 DBMET00172 0.06 0.008 DBMET01292 | DBMET01292 | |
| 0.097 | 0.064 | 0.097 | MAP kinase 8 inhibitor | 0.084 0.082 DBMET01292 | ||
| 0.103 | 0.071 | 0.103 | Protein kinase C gamma inhibitor | |||
| 0.037 | 0.005 | 0.037 | Complement factor 1r inhibitor | 0.032 0.009 DBMET00169 0.032 0.009 DBMET01838 | ||
| 0.049 | 0.017 | 0.064 | Alpha 1d adrenoreceptor agonist | 0.035 0.033 DBMET00169 0.047 0.018 DBMET00170 0.035 0.033 DBMET01838 0.064 0.009 DBMET01292 | DBMET01292 | |
| 0.203 | 0.173 | 0.645 | Antithrombotic | 0.304 0.085 DBMET00169 0.398 0.05 DBMET00170 0.383 0.054 DBMET00171 0.383 0.054 DBMET00172 0.304 0.085 DBMET01838 0.645 0.012 DBMET01294 | DBMET01294 | |
| 0.083 | 0.052 | 0.083 | Ca(v)3.1 blocker | |||
| 0.071 | 0.042 | 0.071 | Carbonic anhydrase V inhibitor | |||
| 0.043 | 0.014 | 0.043 | ATM kinase inhibitor | |||
| 0.04 | 0.012 | 0.04 | ATR kinase inhibitor | 0.035 0.018 DBMET01292 | ||
| 0.046 | 0.02 | 0.046 | Progesterone antagonist | |||
| 0.158 | 0.132 | 0.158 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.113 | 0.087 | 0.113 | Tubulin antagonist | |||
| 0.053 | 0.029 | 0.057 | Alpha 1b adrenoreceptor agonist | 0.047 0.043 DBMET00170 0.057 0.023 DBMET01292 | DBMET01292 | |
| 0.027 | 0.005 | 0.03 | Sodium/hydrogen exchanger inhibitor | 0.016 0.014 DBMET00169 0.019 0.01 DBMET00170 0.021 0.008 DBMET00171 0.021 0.008 DBMET00172 0.016 0.014 DBMET01838 0.03 0.005 DBMET01292 | DBMET01292 | |
| 0.043 | 0.021 | 0.043 | Growth hormone secretagogue receptor agonist | |||
| 0.03 | 0.008 | 0.03 | Complement factor 1s inhibitor | |||
| 0.071 | 0.052 | 0.071 | Epoxide hydrolase inhibitor | |||
| 0.067 | 0.048 | 0.067 | Acetylcholine M5 receptor agonist | |||
| 0.028 | 0.009 | 0.028 | Inosine monophosphate dehydrogenase 1 inhibitor | |||
| 0.025 | 0.007 | 0.025 | Alpha 2a adrenoreceptor agonist | 0.019 0.01 DBMET01292 | ||
| 0.115 | 0.097 | 0.23 | Interleukin 1 antagonist | 0.23 0.023 DBMET00169 0.23 0.023 DBMET01838 | DBMET01838 | |
| 0.051 | 0.033 | 0.051 | Squalene epoxidase inhibitor | 0.05 0.033 DBMET00169 0.05 0.033 DBMET01838 | ||
| 0.073 | 0.055 | 0.073 | CYP2A6 inhibitor | |||
| 0.022 | 0.006 | 0.022 | Complement factor 1 inhibitor | 0.018 0.011 DBMET00169 0.018 0.011 DBMET01838 | ||
| 0.04 | 0.027 | 0.069 | Dihydropteroate synthase inhibitor | 0.069 0.009 DBMET00171 0.069 0.009 DBMET00172 | DBMET00172 | |
| 0.054 | 0.041 | 0.054 | MAP kinase kinase 9 inhibitor | |||
| 0.109 | 0.096 | 0.143 | Sphingosine 1-phosphate receptor 4 antagonist | 0.143 0.04 DBMET00171 0.143 0.04 DBMET00172 0.106 0.104 DBMET01292 | DBMET00172 | |
| 0.065 | 0.052 | 0.11 | Phenylalanine 4-hydroxylase inhibitor | 0.11 0.021 DBMET00171 0.11 0.021 DBMET00172 | DBMET00172 | |
| 0.04 | 0.029 | 0.04 | Phenylethanolamine N methyltransferase inhibitor | 0.038 0.033 DBMET00171 0.038 0.033 DBMET00172 | ||
| 0.065 | 0.055 | 0.065 | Exportin-1 inhibitor | |||
| 0.055 | 0.045 | 0.063 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.058 0.042 DBMET00169 0.063 0.037 DBMET00171 0.063 0.037 DBMET00172 0.058 0.042 DBMET01838 0.063 0.037 DBMET01294 | DBMET01294 | |
| 0.117 | 0.107 | 0.174 | Mannose-6-phosphate isomerase inhibitor | 0.174 0.046 DBMET00169 0.126 0.092 DBMET00171 0.126 0.092 DBMET00172 0.174 0.046 DBMET01838 0.146 0.068 DBMET01294 | DBMET01838 | |
| 0.041 | 0.032 | 0.041 | Leukocyte elastase inhibitor | |||
| 0.015 | 0.007 | 0.015 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.031 | 0.023 | 0.031 | Glucocorticoid antagonist | |||
| 0.013 | 0.007 | 0.013 | Glucose-dependent insulinotropic receptor antagonist | 0.012 0.009 DBMET01292 | ||
| 0.045 | 0.039 | 0.064 | Glucose-6-phosphate isomerase inhibitor | 0.061 0.018 DBMET00169 0.054 0.024 DBMET00170 0.061 0.018 DBMET00171 0.061 0.018 DBMET00172 0.061 0.018 DBMET01838 0.064 0.016 DBMET01294 | DBMET01294 | |
| 0.063 | 0.058 | 0.063 | MAP kinase kinase 8 inhibitor | |||
| 0.129 | 0.125 | 0.157 | Ca2+-transporting ATPase inhibitor | 0.152 0.038 DBMET00169 0.157 0.029 DBMET00170 0.139 0.077 DBMET00171 0.139 0.077 DBMET00172 0.152 0.038 DBMET01838 0.133 0.102 DBMET01294 0.134 0.1 DBMET01292 | DBMET00170 | |
| 0.024 | 0.019 | 0.039 | Prostaglandin H2 antagonist | 0.039 0.006 DBMET00171 0.039 0.006 DBMET00172 | DBMET00172 | |
| 0.018 | 0.014 | 0.021 | Alpha 2c adrenoreceptor agonist | 0.021 0.01 DBMET01292 | DBMET01292 | |
| 0.037 | 0.033 | 0.065 | Glucagon-like peptide 1 receptor antagonist | 0.038 0.032 DBMET00170 0.065 0.007 DBMET00171 0.065 0.007 DBMET00172 0.045 0.018 DBMET01292 | DBMET00172 | |
| 0.021 | 0.017 | 0.029 | Alpha 1a adrenoreceptor agonist | 0.029 0.011 DBMET01292 | DBMET01292 | |
| 0.019 | 0.016 | 0.052 | Hexokinase stimulant | 0.052 0.005 DBMET00171 0.052 0.005 DBMET00172 0.021 0.013 DBMET01292 | DBMET00172 | |
| 0.026 | 0.023 | 0.026 | Hedgehog signaling activator | |||
| 0.051 | 0.048 | 0.061 | Dihydroorotate oxidase inhibitor | 0.061 0.028 DBMET00171 0.061 0.028 DBMET00172 | DBMET00172 | |
| 0.052 | 0.05 | 0.052 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.108 | 0.108 | 0.156 | Protein kinase stimulant | 0.121 0.092 DBMET00169 0.114 0.099 DBMET00170 0.11 0.104 DBMET00171 0.11 0.104 DBMET00172 0.121 0.092 DBMET01838 0.156 0.064 DBMET01294 | DBMET01294 | |
| 0.088 | 0.09 | 0.104 | Glutamate (mGluR7) agonist | 0.104 0.051 DBMET00171 0.104 0.051 DBMET00172 | DBMET00172 | |
| 0.136 | 0.138 | 0.259 | Phospholipase C inhibitor | 0.16 0.089 DBMET00169 0.17 0.073 DBMET00170 0.259 0.023 DBMET00171 0.259 0.023 DBMET00172 0.16 0.089 DBMET01838 0.145 0.116 DBMET01292 | DBMET00172 | |
| 0.027 | 0.03 | 0.031 | Sirtuin 2 inhibitor | 0.031 0.025 DBMET01292 | DBMET01292 | |
| 0.078 | 0.084 | 0.142 | Aminopeptidase B inhibitor | 0.142 0.041 DBMET00171 0.142 0.041 DBMET00172 | DBMET00172 | |
| 0.05 | 0.057 | 0.053 | Androgen agonist | 0.053 0.051 DBMET00169 0.053 0.051 DBMET01838 | DBMET01838 | |
| 0.096 | 0.106 | 0.133 | Aldehyde dehydrogenase inhibitor | 0.133 0.059 DBMET00169 0.133 0.059 DBMET01838 | DBMET01838 | |
| 0.068 | 0.078 | 0.102 | Ca(v)2.2 blocker | 0.102 0.047 DBMET01292 | DBMET01292 | |
| 0.049 | 0.06 | 0.07 | Collagenase 3 inhibitor | 0.07 0.032 DBMET00171 0.07 0.032 DBMET00172 | DBMET00172 | |
| 0.059 | 0.071 | 0.077 | Carbonic anhydrase XIII inhibitor | 0.077 0.052 DBMET01294 | DBMET01294 | |
| 0.059 | 0.071 | 0.066 | Cathepsin G inhibitor | 0.066 0.058 DBMET00171 0.066 0.058 DBMET00172 | DBMET00172 | |
| 0.058 | 0.071 | 0.106 | Porphobilinogen synthase inhibitor | 0.106 0.033 DBMET00171 0.106 0.033 DBMET00172 | DBMET00172 | |
| 0.04 | 0.056 | 0.051 | Topoisomerase II beta inhibitor | 0.051 0.031 DBMET01292 | DBMET01292 | |
| 0.063 | 0.079 | 0.096 | Metalloproteinase-2 inhibitor | 0.096 0.04 DBMET00171 0.096 0.04 DBMET00172 | DBMET00172 | |
| 0.091 | 0.108 | 0.12 | Photosensitizer | 0.104 0.08 DBMET00169 0.104 0.08 DBMET01838 0.12 0.057 DBMET01294 | DBMET01294 | |
| 0.01 | 0.027 | 0.023 | Thyroid hormone alpha antagonist | 0.023 0.006 DBMET00171 0.023 0.006 DBMET00172 | DBMET00172 | |
| 0.05 | 0.069 | 0.137 | Phosphofructokinase-1 inhibitor | 0.072 0.046 DBMET00169 0.06 0.057 DBMET00170 0.1 0.032 DBMET00171 0.1 0.032 DBMET00172 0.072 0.046 DBMET01838 0.137 0.021 DBMET01294 | DBMET01294 | |
| 0.042 | 0.061 | 0.086 | Glucose-6-phosphate translocase inhibitor | 0.05 0.038 DBMET00169 0.05 0.038 DBMET01838 0.086 0.009 DBMET01294 | DBMET01294 | |
| 0.067 | 0.089 | 0.075 | Glutathione S-transferase inhibitor | 0.075 0.07 DBMET00171 0.075 0.07 DBMET00172 | DBMET00172 | |
| 0.06 | 0.082 | 0.072 | Glycine receptor agonist | 0.072 0.05 DBMET00170 0.068 0.059 DBMET01292 | DBMET00170 | |
| 0.091 | 0.115 | 0.233 | Alpha-N-acetylglucosaminidase inhibitor | 0.186 0.038 DBMET00169 0.144 0.059 DBMET00170 0.233 0.026 DBMET00171 0.233 0.026 DBMET00172 0.186 0.038 DBMET01838 0.193 0.036 DBMET01294 | DBMET00172 | |
| 0.059 | 0.084 | 0.069 | Metalloproteinase-9 inhibitor | 0.069 0.057 DBMET00171 0.069 0.057 DBMET00172 | DBMET00172 | |
| 0.04 | 0.067 | 0.048 | Cytokine production stimulant | 0.048 0.034 DBMET01294 | DBMET01294 | |
| 0.013 | 0.041 | 0.028 | Antibiotic Anthracycline-like | 0.028 0.004 DBMET01294 | DBMET01294 | |
| 0.012 | 0.041 | 0.037 | CXC chemokine 5 receptor antagonist | 0.037 0.003 DBMET00171 0.037 0.003 DBMET00172 | DBMET00172 | |
| 0.051 | 0.084 | 0.087 | Na+ K+ transporting ATPase inhibitor | 0.066 0.063 DBMET00169 0.087 0.044 DBMET00170 0.066 0.063 DBMET01838 0.086 0.045 DBMET01294 0.068 0.062 DBMET01292 | DBMET00170 | |
| 0.074 | 0.108 | 0.158 | Interleukin 1 beta converting enzyme inhibitor | 0.158 0.014 DBMET00169 0.084 0.083 DBMET00170 0.158 0.014 DBMET01838 | DBMET01838 | |
| 0.081 | 0.115 | 0.101 | GABA C receptor antagonist | 0.101 0.076 DBMET01292 | DBMET01292 | |
| 0.039 | 0.074 | 0.056 | Matrix metalloproteinase (membrane-type) inhibitor | 0.056 0.037 DBMET00171 0.056 0.037 DBMET00172 | DBMET00172 | |
| 0.08 | 0.116 | 0.109 | Adenylate kinase inhibitor | 0.109 0.054 DBMET00171 0.109 0.054 DBMET00172 | DBMET00172 | |
| 0.069 | 0.105 | 0.132 | NADH dehydrogenase inhibitor | 0.099 0.044 DBMET00169 0.083 0.068 DBMET00170 0.092 0.054 DBMET00171 0.092 0.054 DBMET00172 0.099 0.044 DBMET01838 0.132 0.023 DBMET01294 | DBMET01294 | |
| 0.112 | 0.15 | 0.178 | Sphingosine 1-phosphate receptor 5 antagonist | 0.178 0.026 DBMET00171 0.178 0.026 DBMET00172 | DBMET00172 | |
| 0.032 | 0.072 | 0.103 | Protein 50S ribosomal subunit inhibitor | 0.056 0.034 DBMET00169 0.059 0.032 DBMET00170 0.056 0.034 DBMET01838 0.103 0.012 DBMET01294 | DBMET01294 | |
| 0.065 | 0.105 | 0.096 | Caspase 7 inhibitor | 0.096 0.033 DBMET00169 0.096 0.033 DBMET01838 | DBMET01838 | |
| 0.107 | 0.147 | 0.197 | Arachidonic acid antagonist | 0.197 0.035 DBMET00171 0.197 0.035 DBMET00172 | DBMET00172 | |
| 0.102 | 0.142 | 0.207 | Phospholipase A2 inhibitor | 0.207 0.039 DBMET00169 0.18 0.054 DBMET00170 0.131 0.099 DBMET00171 0.131 0.099 DBMET00172 0.207 0.039 DBMET01838 | DBMET01838 | |
| 0.159 | 0.202 | 0.217 | Thyroid hormone antagonist | 0.217 0.147 DBMET00171 0.217 0.147 DBMET00172 | DBMET00172 | |
| 0.05 | 0.094 | 0.178 | Topoisomerase II alpha inhibitor | 0.085 0.049 DBMET01294 0.178 0.018 DBMET01292 | DBMET01292 | |
| 0.039 | 0.085 | 0.067 | Neutrophil collagenase inhibitor | 0.067 0.043 DBMET00171 0.067 0.043 DBMET00172 | DBMET00172 | |
| 0.083 | 0.129 | 0.344 | Bone formation stimulant | 0.344 0.013 DBMET00169 0.168 0.047 DBMET00170 0.344 0.013 DBMET01838 0.156 0.054 DBMET01294 | DBMET01838 | |
| 0.124 | 0.17 | 0.166 | Insulin sensitizer | 0.166 0.112 DBMET00171 0.166 0.112 DBMET00172 | DBMET00172 | |
| 0.008 | 0.058 | 0.05 | Prostaglandin D2 antagonist | 0.05 0.007 DBMET00171 0.05 0.007 DBMET00172 | DBMET00172 | |
| 0.028 | 0.078 | 0.083 | Prostaglandin antagonist | 0.083 0.022 DBMET00171 0.083 0.022 DBMET00172 | DBMET00172 | |
| 0.022 | 0.072 | 0.222 | Estrogen agonist | 0.222 0.007 DBMET01292 | DBMET01292 | |
| 0.013 | 0.064 | 0.032 | Sodium/glucose cotransporter 2 inhibitor | 0.032 0.011 DBMET01294 | DBMET01294 | |
| 0.079 | 0.133 | 0.111 | Microtubule formation inhibitor | 0.111 0.072 DBMET01292 | DBMET01292 | |
| 0.034 | 0.092 | 0.068 | Alpha-mannosidase inhibitor | 0.052 0.039 DBMET00169 0.052 0.04 DBMET00170 0.053 0.037 DBMET00171 0.053 0.037 DBMET00172 0.052 0.039 DBMET01838 0.068 0.018 DBMET01294 | DBMET01294 | |
| 0.085 | 0.143 | 0.194 | Interleukin 8 antagonist | 0.194 0.014 DBMET00171 0.194 0.014 DBMET00172 | DBMET00172 | |
| 0.037 | 0.096 | 0.066 | Matrix metalloproteinase inhibitor | 0.066 0.047 DBMET00171 0.066 0.047 DBMET00172 | DBMET00172 | |
| 0.022 | 0.082 | 0.045 | Retinoid X alpha receptor antagonist | 0.045 0.01 DBMET00171 0.045 0.01 DBMET00172 | DBMET00172 | |
| 0.024 | 0.085 | 0.051 | Retinoid X receptor antagonist | 0.051 0.011 DBMET00171 0.051 0.011 DBMET00172 | DBMET00172 | |
| 0.104 | 0.169 | 0.394 | Nitric oxide antagonist | 0.186 0.073 DBMET00169 0.252 0.051 DBMET00170 0.186 0.073 DBMET01838 0.394 0.026 DBMET01294 0.151 0.093 DBMET01292 | DBMET01294 | |
| 0.097 | 0.163 | 0.162 | Hexokinase inhibitor | 0.128 0.106 DBMET00169 0.128 0.106 DBMET01838 0.162 0.065 DBMET01294 | DBMET01294 | |
| 0.079 | 0.145 | 0.16 | Cyclooxygenase 3 inhibitor | 0.136 0.061 DBMET00171 0.136 0.061 DBMET00172 0.16 0.041 DBMET01294 | DBMET01294 | |
| 0.048 | 0.118 | 0.108 | Ornithine decarboxylase inhibitor | 0.108 0.036 DBMET00169 0.093 0.052 DBMET00170 0.108 0.036 DBMET01838 | DBMET01838 | |
| 0.074 | 0.146 | 0.141 | Caspase 3 inhibitor | 0.141 0.035 DBMET00169 0.119 0.062 DBMET00170 0.113 0.07 DBMET00171 0.113 0.07 DBMET00172 0.141 0.035 DBMET01838 | DBMET01838 | |
| 0.118 | 0.195 | 0.496 | Free radical scavenger | 0.228 0.079 DBMET00169 0.226 0.08 DBMET00170 0.228 0.079 DBMET01838 0.496 0.017 DBMET01294 | DBMET01294 | |
| 0.022 | 0.1 | 0.06 | Mannosidase inhibitor | 0.06 0.017 DBMET01294 | DBMET01294 | |
| 0.013 | 0.092 | 0.027 | Sodium/glucose cotransporter inhibitor | 0.027 0.016 DBMET01294 | DBMET01294 | |
| 0.142 | 0.221 | 0.171 | RNA-directed DNA polymerase inhibitor | 0.171 0.151 DBMET00169 0.171 0.151 DBMET01838 | DBMET01838 | |
| 0.023 | 0.103 | 0.055 | Carbonic anhydrase XIV inhibitor | 0.055 0.028 DBMET01294 | DBMET01294 | |
| 0.03 | 0.11 | 0.057 | Aconitate hydratase inhibitor | 0.057 0.029 DBMET00171 0.057 0.029 DBMET00172 | DBMET00172 | |
| 0.062 | 0.145 | 0.098 | Cystathionine beta-synthase inhibitor | 0.098 0.08 DBMET00169 0.098 0.08 DBMET01838 | DBMET01838 | |
| 0.059 | 0.143 | 0.157 | UDP-glucose 4-epimerase inhibitor | 0.106 0.055 DBMET00169 0.084 0.082 DBMET00170 0.106 0.055 DBMET01838 0.157 0.027 DBMET01294 | DBMET01294 | |
| 0.009 | 0.093 | 0.077 | Endothelin receptor antagonist | 0.077 0.006 DBMET00171 0.077 0.006 DBMET00172 | DBMET00172 | |
| 0.014 | 0.1 | 0.037 | AMPA receptor agonist | 0.037 0.022 DBMET00171 0.037 0.022 DBMET00172 0.036 0.023 DBMET01292 | DBMET00172 | |
| 0.121 | 0.208 | 0.538 | Antioxidant | 0.228 0.097 DBMET00169 0.228 0.097 DBMET01838 0.538 0.016 DBMET01294 | DBMET01294 | |
| 0.02 | 0.111 | 0.086 | Aldose reductase inhibitor | 0.086 0.021 DBMET00171 0.086 0.021 DBMET00172 0.062 0.031 DBMET01294 | DBMET00172 | |
| 0.031 | 0.126 | 0.057 | Leukotriene antagonist | 0.057 0.055 DBMET00171 0.057 0.055 DBMET00172 | DBMET00172 | |
| 0.07 | 0.168 | 0.093 | DOPA decarboxylase inhibitor | 0.093 0.09 DBMET00171 0.093 0.09 DBMET00172 | DBMET00172 | |
| 0.063 | 0.162 | 0.147 | Alkylator | 0.147 0.048 DBMET01294 | DBMET01294 | |
| 0.032 | 0.131 | 0.061 | Thromboxane synthase inhibitor | 0.061 0.026 DBMET00171 0.061 0.026 DBMET00172 | DBMET00172 | |
| 0.088 | 0.188 | 0.12 | DNA repair enzyme inhibitor | 0.12 0.071 DBMET01294 | DBMET01294 | |
| 0.027 | 0.127 | 0.062 | Carbamoyl phosphate synthetase inhibitor | 0.062 0.041 DBMET00171 0.062 0.041 DBMET00172 | DBMET00172 | |
| 0.018 | 0.119 | 0.054 | Ornithine carbamoyltransferase inhibitor | 0.054 0.036 DBMET00171 0.054 0.036 DBMET00172 | DBMET00172 | |
| 0.027 | 0.128 | 0.052 | Biliverdin reductase inhibitor | 0.052 0.049 DBMET00171 0.052 0.049 DBMET00172 | DBMET00172 | |
| 0.055 | 0.161 | 0.081 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.081 0.079 DBMET00171 0.081 0.079 DBMET00172 | DBMET00172 | |
| 0.019 | 0.127 | 0.033 | Glutamate (mGluR3) agonist | 0.033 0.021 DBMET00171 0.033 0.021 DBMET00172 | DBMET00172 | |
| 0.044 | 0.158 | 0.113 | Glycine receptor antagonist | 0.113 0.022 DBMET00170 | DBMET00170 | |
| 0.03 | 0.149 | 0.06 | Epithelial sodium channel blocker | 0.06 0.028 DBMET00171 0.06 0.028 DBMET00172 | DBMET00172 | |
| 0.022 | 0.142 | 0.057 | Alcohol oxidase inhibitor | 0.057 0.038 DBMET00171 0.057 0.038 DBMET00172 | DBMET00172 | |
| 0.052 | 0.172 | 0.101 | GABA C receptor agonist | 0.101 0.065 DBMET00171 0.101 0.065 DBMET00172 | DBMET00172 | |
| 0.04 | 0.163 | 0.065 | Glutamate dehydrogenase inhibitor | 0.065 0.064 DBMET00171 0.065 0.064 DBMET00172 | DBMET00172 | |
| 0.004 | 0.128 | 0.02 | Free fatty acid receptor 1 agonist | 0.02 0.01 DBMET00171 0.02 0.01 DBMET00172 | DBMET00172 | |
| 0.125 | 0.252 | 0.21 | 12-Lipoxygenase inhibitor | 0.21 0.14 DBMET00169 0.21 0.14 DBMET01838 | DBMET01838 | |
| 0.09 | 0.217 | 0.124 | Adenylate cyclase stimulant | 0.124 0.115 DBMET00171 0.124 0.115 DBMET00172 | DBMET00172 | |
| 0.093 | 0.225 | 0.351 | Hypolipemic | 0.351 0.035 DBMET00171 0.351 0.035 DBMET00172 0.276 0.057 DBMET01294 | DBMET00172 | |
| 0.087 | 0.222 | 0.458 | Hepatoprotectant | 0.196 0.068 DBMET00169 0.286 0.034 DBMET00170 0.196 0.068 DBMET01838 0.458 0.009 DBMET01294 0.165 0.095 DBMET01292 | DBMET01294 | |
| 0.145 | 0.286 | 0.201 | Toll-Like receptor 7 agonist | 0.201 0.199 DBMET00171 0.201 0.199 DBMET00172 | DBMET00172 | |
| 0.082 | 0.228 | 0.157 | Sphingosine 1-phosphate receptor 2 antagonist | 0.157 0.032 DBMET00171 0.157 0.032 DBMET00172 | DBMET00172 | |
| 0.031 | 0.182 | 0.078 | Aminopeptidase I inhibitor | 0.078 0.044 DBMET00171 0.078 0.044 DBMET00172 | DBMET00172 | |
| 0.083 | 0.236 | 0.162 | Hemostatic | 0.162 0.055 DBMET01294 | DBMET01294 | |
| 0.028 | 0.184 | 0.065 | Glutamate decarboxylase inhibitor | 0.065 0.061 DBMET00171 0.065 0.061 DBMET00172 | DBMET00172 | |
| 0.04 | 0.199 | 0.07 | Peroxisome proliferator-activated receptor gamma antagonist | 0.07 0.053 DBMET00171 0.07 0.053 DBMET00172 | DBMET00172 | |
| 0.02 | 0.179 | 0.238 | Antineoplastic antibiotic | 0.095 0.049 DBMET00169 0.095 0.049 DBMET01838 0.238 0.016 DBMET01294 | DBMET01294 | |
| 0.006 | 0.172 | 0.026 | CXC chemokine 2 receptor antagonist | 0.026 0.019 DBMET00171 0.026 0.019 DBMET00172 | DBMET00172 | |
| 0.055 | 0.223 | 0.195 | Toll-Like receptor 4 antagonist | 0.142 0.026 DBMET00169 0.195 0.007 DBMET00170 0.138 0.028 DBMET00171 0.138 0.028 DBMET00172 0.142 0.026 DBMET01838 0.193 0.007 DBMET01294 | DBMET00170 | |
| 0.012 | 0.195 | 0.046 | Macrophage elastase inhibitor | 0.046 0.028 DBMET00171 0.046 0.028 DBMET00172 | DBMET00172 | |
| 0.078 | 0.262 | 0.114 | Vanilloid 1 agonist | 0.114 0.103 DBMET00171 0.114 0.103 DBMET00172 | DBMET00172 | |
| 0.07 | 0.276 | 0.148 | Interleukin antagonist | 0.148 0.119 DBMET00169 0.148 0.119 DBMET01838 | DBMET01838 | |
| 0.097 | 0.306 | 0.217 | Superoxide dismutase inhibitor | 0.217 0.1 DBMET00171 0.217 0.1 DBMET00172 | DBMET00172 | |
| 0.061 | 0.272 | 0.169 | Cell wall synthesis inhibitor | 0.169 0.048 DBMET01294 | DBMET01294 | |
| 0.052 | 0.268 | 0.083 | Estrogen-related receptor beta agonist | 0.083 0.059 DBMET00171 0.083 0.059 DBMET00172 | DBMET00172 | |
| 0.072 | 0.289 | 0.478 | Platelet antagonist | 0.218 0.089 DBMET00169 0.218 0.089 DBMET01838 0.478 0.016 DBMET01294 | DBMET01294 | |
| 0.025 | 0.242 | 0.062 | Prostaglandin F2 alpha antagonist | 0.062 0.043 DBMET00171 0.062 0.043 DBMET00172 | DBMET00172 | |
| 0.059 | 0.29 | 0.182 | Anesthetic general | 0.182 0.085 DBMET00171 0.182 0.085 DBMET00172 | DBMET00172 | |
| 0.049 | 0.293 | 0.089 | Phosphodiesterase 6D inhibitor | 0.089 0.079 DBMET01294 | DBMET01294 | |
| 0.094 | 0.34 | 0.191 | DNA synthesis inhibitor | 0.191 0.137 DBMET01294 | DBMET01294 | |
| 0.098 | 0.361 | 0.804 | Nootropic | 0.804 0.005 DBMET00171 0.804 0.005 DBMET00172 | DBMET00172 | |
| 0.02 | 0.283 | 0.061 | Heparanase inhibitor | 0.061 0.021 DBMET01294 | DBMET01294 | |
| 0.037 | 0.308 | 0.143 | Falcipain 2 inhibitor | 0.142 0.032 DBMET00169 0.143 0.032 DBMET00170 0.142 0.032 DBMET01838 | DBMET00170 | |
| 0.012 | 0.288 | 0.102 | HIV-1 integrase (3'-Processing) inhibitor | 0.102 0.025 DBMET00169 0.102 0.025 DBMET01838 | DBMET01838 | |
| 0.036 | 0.318 | 0.144 | Falcipain inhibitor | 0.143 0.034 DBMET00169 0.144 0.033 DBMET00170 0.143 0.034 DBMET01838 | DBMET00170 | |
| 0.036 | 0.319 | 0.126 | Protein-tyrosine phosphatase inhibitor | 0.126 0.106 DBMET01294 | DBMET01294 | |
| 0.033 | 0.322 | 0.06 | Lipocortins synthesis agonist | 0.06 0.036 DBMET01294 | DBMET01294 | |
| 0.095 | 0.396 | 0.276 | Vasodilator, coronary | 0.276 0.109 DBMET01294 | DBMET01294 | |
| 0.054 | 0.358 | 0.308 | Platelet adhesion inhibitor | 0.308 0.031 DBMET01294 | DBMET01294 | |
| 0.033 | 0.341 | 0.08 | GABA B receptor agonist | 0.08 0.042 DBMET00171 0.08 0.042 DBMET00172 | DBMET00172 | |
| 0.009 | 0.321 | 0.059 | Caspase 6 inhibitor | 0.059 0.004 DBMET00169 0.051 0.005 DBMET00170 0.059 0.004 DBMET01838 | DBMET01838 | |
| 0.007 | 0.324 | 0.073 | Prostaglandin EP2 antagonist | 0.073 0.031 DBMET01294 | DBMET01294 | |
| 0.089 | 0.409 | 0.143 | CC chemokine 6 receptor antagonist | 0.143 0.033 DBMET01294 | DBMET01294 | |
| 0.066 | 0.394 | 0.267 | Alpha-glucosidase inhibitor | 0.267 0.177 DBMET01294 | DBMET01294 | |
| 0.03 | 0.362 | 0.126 | Beta glucuronidase inhibitor | 0.126 0.041 DBMET01294 | DBMET01294 | |
| 0.076 | 0.413 | 0.236 | Cholesterol antagonist | 0.236 0.135 DBMET00170 0.214 0.152 DBMET00171 0.214 0.152 DBMET00172 0.234 0.137 DBMET01294 | DBMET00170 | |
| 0.049 | 0.388 | 0.169 | Interleukin agonist | 0.169 0.149 DBMET01294 | DBMET01294 | |
| 0.036 | 0.385 | 0.669 | Angiogenesis stimulant | 0.168 0.111 DBMET00169 0.167 0.112 DBMET00170 0.227 0.081 DBMET00171 0.227 0.081 DBMET00172 0.168 0.111 DBMET01838 0.669 0.005 DBMET01294 | DBMET01294 | |
| 0.084 | 0.436 | 0.597 | Antibacterial | 0.241 0.185 DBMET00169 0.248 0.179 DBMET00170 0.241 0.185 DBMET01838 0.597 0.02 DBMET01294 | DBMET01294 | |
| 0.008 | 0.385 | 0.084 | HIV-1 integrase (Strand Transfer) inhibitor | 0.084 0.029 DBMET00169 0.084 0.029 DBMET01838 | DBMET01838 | |
| 0.032 | 0.414 | 0.154 | Anticoagulant | 0.143 0.087 DBMET00171 0.143 0.087 DBMET00172 0.154 0.077 DBMET01294 | DBMET01294 | |
| 0.005 | 0.39 | 0.032 | Prostacyclin antagonist | 0.032 0.024 DBMET00171 0.032 0.024 DBMET00172 | DBMET00172 | |
| 0.019 | 0.429 | 0.083 | Histone deacetylase SIRT1 stimulant | 0.079 0.045 DBMET00169 0.077 0.047 DBMET00170 0.079 0.045 DBMET01838 0.083 0.041 DBMET01294 | DBMET01294 | |
| 0.019 | 0.429 | 0.083 | Histone deacetylase stimulant | 0.079 0.045 DBMET00169 0.077 0.047 DBMET00170 0.079 0.045 DBMET01838 0.083 0.041 DBMET01294 | DBMET01294 | |
| 0.041 | 0.468 | 0.326 | Tumour necrosis factor alpha release inhibitor | 0.326 0.045 DBMET01294 | DBMET01294 | |
| 0.005 | 0.449 | 0.581 | Secretase gamma inhibitor | 0.581 0.002 DBMET00171 0.581 0.002 DBMET00172 | DBMET00172 | |
| 0.016 | 0.481 | 0.063 | CXC chemokine 1 receptor antagonist | 0.063 0.018 DBMET00171 0.063 0.018 DBMET00172 | DBMET00172 | |
| 0.071 | 0.548 | 0.416 | Apoptosis antagonist | 0.301 0.085 DBMET00170 0.416 0.034 DBMET01294 | DBMET01294 | |
| 0.021 | 0.532 | 0.056 | Adenine nucleotide translocase inhibitor | 0.056 0.037 DBMET01294 | DBMET01294 | |
| 0.025 | 0.537 | 0.157 | Cell adhesion inhibitor | 0.157 0.042 DBMET00171 0.157 0.042 DBMET00172 0.145 0.05 DBMET01294 | DBMET00172 | |
| 0.005 | 0.536 | 0.189 | Caspase 2 inhibitor | 0.189 0.003 DBMET00169 0.181 0.003 DBMET00170 0.189 0.003 DBMET01838 0.034 0.02 DBMET01294 | DBMET01838 | |
| 0.019 | 0.621 | 0.255 | Amyloid beta precursor protein antagonist | 0.255 0.031 DBMET00171 0.255 0.031 DBMET00172 | DBMET00172 | |
| 0.069 | 0.672 | 0.381 | Interleukin 2 agonist | 0.202 0.186 DBMET00169 0.212 0.169 DBMET00170 0.25 0.118 DBMET00171 0.25 0.118 DBMET00172 0.202 0.186 DBMET01838 0.381 0.034 DBMET01294 | DBMET01294 | |
| 0.02 | 0.629 | 0.129 | Farnesoid X receptor antagonist | 0.129 0.085 DBMET00170 | DBMET00170 | |
| 0.01 | 0.656 | 0.075 | Antibiotic Aminoglycoside-like | 0.033 0.03 DBMET00169 0.033 0.03 DBMET01838 0.075 0.005 DBMET01294 | DBMET01294 | |
| 0.01 | 0.668 | 0.181 | Lipid peroxidase inhibitor | 0.181 0.05 DBMET01294 | DBMET01294 | |
| 0.004 | 0.733 | 0.197 | Neurokinin 1 antagonist | 0.197 0.004 DBMET00170 | DBMET00170 | |
| 0.022 | 0.781 | 0.308 | Immunomodulator | 0.308 0.078 DBMET01294 | DBMET01294 | |
| 0.004 | 0.779 | 0.171 | Neurokinin antagonist | 0.171 0.005 DBMET00170 | DBMET00170 | |
| 0.004 | 0.792 | 0.3 | Selectin antagonist | 0.3 0.005 DBMET01294 | DBMET01294 | |
| 0.003 | 0.793 | 0.048 | Substance P antagonist | 0.048 0.018 DBMET00170 | DBMET00170 | |
| 0.011 | 0.801 | 0.051 | Factor IXa inhibitor | 0.051 0.036 DBMET01294 | DBMET01294 | |
| 0.021 | 0.822 | 0.126 | Transcription factor NF kappa B stimulant | 0.121 0.025 DBMET00169 0.123 0.024 DBMET00170 0.121 0.025 DBMET01838 0.126 0.023 DBMET01294 | DBMET01294 | |
| 0.005 | 0.823 | 0.077 | Cell adhesion molecule inhibitor | 0.077 0.057 DBMET00171 0.077 0.057 DBMET00172 | DBMET00172 | |
| 0.007 | 0.865 | 0.168 | Thrombolytic | 0.124 0.106 DBMET00171 0.124 0.106 DBMET00172 0.168 0.069 DBMET01294 | DBMET01294 | |
| 0.006 | 0.875 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.009 DBMET01294 | DBMET01294 | |
| 0.003 | 0.872 | 0.044 | Protein 30S ribosomal subunit inhibitor | 0.044 0.009 DBMET01294 | DBMET01294 | |
| 0.02 | 0.949 | 0.127 | NOS3 expression enhancer | 0.127 0.103 DBMET01294 | DBMET01294 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |